Research progress on SARS-CoV-2
Chinese Journal of Virology
; 36(3):493-501, 2020.
Article
in Chinese
| GIM | ID: covidwho-1994545
ABSTRACT
Since December 2019. the outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, has spread rapidly to other provinces and cities in China, and worldwide. Severe acute respiratory syndrome (SARS)-CoV-2 belongs to the fi-coronavirus family, which is closely related to SARS-CoV and Middle East respiratory syndrome (MERS)-CoV, but quite different, especially in the spike protein. SARS-CoV-2 may he derived from bats according to sequence comparison. SARS-CoV-2 uses the same receptor, angiotensin converting enzyme II (ACE2), as SARS-CoV. The main transmission routes include droplets and close contacts. The lack of effective drugs and vaccine is a challenge for outbreak control.
coronavirus disease 2019; human diseases; viral diseases; Severe acute respiratory syndrome coronavirus 2; man; China; Central Southern China; APEC countries; East Asia; Asia; high Human Development Index countries; upper-middle income countries; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; People's Republic of China; SARS-CoV-2; viral infections
Full text:
Available
Collection:
Databases of international organizations
Database:
GIM
Language:
Chinese
Journal:
Chinese Journal of Virology
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS